Home › Research › Long-term cohort studies
rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues
Hu Y, Sun JY, Zhang Y, Zhang H, Gao S, Wang T, Han Z, Wang L et al.. BMC medicine, 2021-01-19
Topic: Brain proteins, microglia and lab models
Plain-language summary
Background It has been well established that the TMEM106B gene rs1990622 variant was a frontotemporal dementia (FTD) risk factor. Until recently, growing evidence highlights the role of TMEM106B in Alzheimer's disease (AD). However, it remains largely unclear about the role of rs1990622 variant in AD.
What this study adds
Evidence grade: Low
The record lists 314,278 participants. This work analysed genetic data to see whether the rs1990622 variant is associated with Alzheimer's disease and regulates TMEM106B expression in brain tissue. It is genetic and gene-expression analysis, so it does not test any treatment, cure or prevention for Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hu, Y., Sun, J. Y., Zhang, Y., Zhang, H., Gao, S., Wang, T., et al. (2021). rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues. BMC medicine. https://doi.org/10.1186/s12916-020-01883-5
Vancouver
Hu Y, Sun JY, Zhang Y, Zhang H, Gao S, Wang T, et al. rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues. BMC medicine. 2021. doi:10.1186/s12916-020-01883-5. PMID: 33461566.
BibTeX
@article{hu2021-33461566,
author = {Hu, Y. and Sun, J. Y. and Zhang, Y. and Zhang, H. and Gao, S. and Wang, T. and Han, Z. and Wang, L. and others},
title = {{rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues}},
journal = {BMC medicine},
year = {2021},
doi = {10.1186/s12916-020-01883-5},
pmid = {33461566},
url = {https://doi.org/10.1186/s12916-020-01883-5}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Until recently, growing evidence highlights the role of TMEM106B in Alzheimer's disease (AD).
- However, it remains largely unclear about the role of rs1990622 variant in AD.
- Methods Here, we conducted comprehensive analyses including genetic association study, gene expression analysis, eQTLs analysis, and colocalization analysis.
- In stage 1, we conducted a genetic association analysis of rs1990622 using large-scale genome-wide association study (GWAS) datasets from International Genomics of Alzheimer's Project (21,982 AD and 41,944 cognitively normal controls) and UK Biobank (314,278 participants).
Why it matters
This work analysed genetic data to see whether the rs1990622 variant is associated with Alzheimer's disease and regulates TMEM106B expression in brain tissue. It is genetic and gene-expression analysis, so it does not test any treatment, cure or prevention for Alzheimer's disease.
Study details
- Participants314,278
- Evidence strengthLow
How this study scored 55/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (BMC medicine) |
| Journal's citation record | 3 / 4 | BMC Medicine: journal h-index 259 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 314,278 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 89 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 12.7 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 4 / 6 | Cited 9.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 2 / 4 | Cited 31 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Guiyou Liu: h-index 39 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Tsinghua University: institution h-index 1,218 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 14 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33461566) |
| Free to read | 2 / 2 | Free to read |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Long-term cohort studies from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.